HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injury.

Abstract
It is still controversial whether intrinsic interferon (IFN)-gamma promotes or attenuates vascular remodeling in hyperproliferative vascular disorders, such as neointima formation after balloon injury. Thus, we investigated whether inhibition of intrinsic IFN-gamma function prevents neointima formation. For this purpose, naked DNA plasmid encoding a soluble mutant of IFN-gamma receptor alpha-subunit (sIFNgammaR; an IFN-gamma inhibitory protein) or mock plasmid was injected into the thigh muscle of male Wistar rats 2 days before balloon injury (day -2). sIFNgammaR gene transfer significantly elevated serum levels of sIFNgammaR protein for 2 weeks. In mock-treated rats, balloon injury induced smooth muscle cell proliferation in the neointima with a peak at day 7 and produced thick neointima at day 14. sIFNgammaR treatment reduced the number of proliferating intimal smooth muscle cells by 50% at day 7 and attenuated neointima formation with a 45% reduction of the intima/media area ratio at day 14. In mock-treated rats, at day 7, balloon injury induced phosphorylation of signal transducer and activator of transcription-1 and upregulations of IFN regulatory factor-1 (a transcription factor mediating IFN-gamma signal). Balloon injury also upregulated the key molecules of neointima formation, such as intercellular adhesion molecule-1 and platelet-derived growth factor beta-receptor. These changes were suppressed by sIFNgammaR treatment. In conclusion, it is suggested that intrinsic IFN-gamma promotes neointima formation probably through IFN regulatory factor-1/intercellular adhesion molecule-1-mediated and platelet-derived growth factor-mediated mechanisms. Thus, inhibition of IFN-gamma signaling may be a new therapeutic target for prevention of neointima formation of hyperproliferative vascular disorders.
AuthorsKen Kusaba, Hisashi Kai, Mitsuhisa Koga, Narimasa Takayama, Ayami Ikeda, Hideo Yasukawa, Yukihiko Seki, Kensuke Egashira, Tsutomu Imaizumi
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 49 Issue 4 Pg. 909-15 (Apr 2007) ISSN: 1524-4563 [Electronic] United States
PMID17309951 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Small Interfering
  • Receptors, Interferon
  • Interferon-gamma
Topics
  • Animals
  • Blood Vessels (injuries, metabolism)
  • Catheterization (adverse effects)
  • Cell Proliferation (drug effects)
  • Gene Expression (drug effects)
  • Gene Transfer Techniques
  • Injections, Intramuscular
  • Interferon-gamma (antagonists & inhibitors)
  • Male
  • Muscle, Smooth, Vascular (drug effects, pathology, physiopathology)
  • Myocytes, Smooth Muscle (drug effects, pathology)
  • RNA, Small Interfering (genetics, pharmacology)
  • Rats
  • Rats, Wistar
  • Receptors, Interferon (genetics)
  • Thigh
  • Time Factors
  • Tunica Intima (pathology, physiopathology)
  • Interferon gamma Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: